Exaggerated hypertensive response to exercise in patients with diastolic heart failure

Hypertension Research

Volumn 31, Issue 4, 2008, Pages 679-684

  Kato, Shinya ^a   Onishi, Katsuya ^a   Yamanaka, Takashi ^a   Takamura, Takeshi ^a   Dohi, Kaoru ^a   Yamada, Norikazu ^a   Wada, Hideo ^a   Nobori, Tsutomu ^a   Ito, Masaaki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Diastolic heart failure; Exercise; Hypertension

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIURETIC AGENT; VASODILATOR AGENT;

AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC HEART FAILURE; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TOLERANCE; FEMALE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE RELAXATION; HUMAN; MALE; QUALITY OF LIFE; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TREADMILL EXERCISE; TREATMENT DURATION;

AGED; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BLOOD PRESSURE; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; HEART FAILURE, DIASTOLIC; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; QUALITY OF LIFE; TETRAZOLES; TREATMENT OUTCOME;

EID: 44649095585     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.679     Document Type: Article

References (20)

1. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss C, Levy D: Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999; 33: 1948-1955.
2. Masoudi FA, Havranek EP, Smith G, et al: Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003; 41: 217-223.
3. Little WC, Ohno M, Kitzman DW, Thomas JD, Cheng CP: Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 1995; 92: 1933-1939.
4. Zile MR, Brutsaert DL: New concept in diastolic dysfunction and diastolic heart failure: part 1. Diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105: 1387-1393.
5. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D: Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2001; 37: 1042-1048.
6. Fleg JL, O'Connor F, Gerstenblith G, et al: Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. J Appl Physiol 1995; 78: 890-900.
7. Fagard R, Staessen J, Thijs L, Amery A: Prognostic significance of exercise versus resting blood pressure in hypertensive men. Hypertension 1991; 17: 574-578.
8. Aldigier JC, Huang H, Dalmay F, et al: Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. J Cardiovasc Pharmacol 1993; 21: 289-295.
9. Cheng CP, Suzuki M, Ohte N, Ohno M, Wang ZM, Little WC: Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure. Circ Res 1996; 78: 880-892.
10. Rector TS, Tschumperlin LK, Kubo SH, et al: Use of the living with heart failure questionnaire to ascertain patients' perspectives on improvement in quality of life versus risk of drug-induced death. J Card Fail 1995; 1: 201-206.
11. Schiller NB, Shah PM, Crawford M, et al: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367.
12. Oh JK, Appleton CP, Hatle LK, et al: The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 1997; 10: 246-270.
13. Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P: Hypertensive urgencies and emergencies: prevalence and clinical presentation. Hypertension 1996; 27: 144-147.
14. Stratton JR, Levy WC, Cerqueira MD, Schwartz RS, Abrass IB: Cardiovascular responses to exercise: effects of aging and exercise training in healthy men. Circulation 1994; 89: 1648-1655.
15. Arita M, Hashizume T, Wanaka Y, et al: Effects of antihypertensive agents on blood pressure during exercise. Hypertens Res 2001; 24: 671-678.
16. Takamura T, Onishi K, Sugimoto T, et al: Patients with a hypertensive response to exercise have impaired left ventricular diastolic function. Hypertens Res 2008; 31: 257-263.
17. Little WC, Braunwald E: Assessment of cardiac function, in Braunwald E (ed): Heart Disease, 5th ed. Philadelphia, W.B. Saunders, 1997, pp 421-444.
18. Warner JG Jr, Metzger DC, Kitzman DW, Wesley DJ, Little WC: Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999; 33: 1567-1572.
19. Hawkins NM, Wang D, McMurray JJ, et al, CHARM Investigators and Committees: Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM program. Heart 2007; 93: 59-64.
20. Yusuf S, Pfeffer MA, Swedberg K, et al, CHARM Investigators and Committees: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777-781.